Literature DB >> 25794217

Clinical evaluation of transforaminal epidural steroid injection in patients with gadolinium enhancing spinal nerves associated with disc herniation.

Hyeong-Jun Tak, Rodney Jones, Yun-Woo Cho, Eun-Hyuk Kim, Sang-Ho Ahn1.   

Abstract

BACKGROUND: Transforaminal epidural steroid injection (TFESI) of corticosteroid is frequently employed to mitigate the painful and disabling symptoms of lumbar disc herniation. However, the treatment outcome of TFESI in patients with radicular pain and inflamed neural structures as assessed by contrast-enhanced magnetic resonance imaging (MRI) has not been forthcoming.
OBJECTIVES: To investigate functional improvement and pain reduction following TFESI in patients found to have nerve inflammation as evidenced by gadolinium-enhanced (MRI). STUDY
DESIGN: Retrospective assessment.
SETTING: Tertiary spinal intervention center, Daegu, Korea.
METHODS: Thirty-seven patients were selected by strict inclusion criteria. Patients were classified into enhancing and non-enhancing groups as evidenced by gadolinium-enhanced MRI. The enhancing group was further divided into pre-dorsal roog ganglion (DRG) only enhanced group and pre-DRG and post-DRG enhanced group. Clinical outcomes were evidenced by numeric rating scale (NRS) and Oswestry disability index (ODI) at pretreatment, one week, and 4 weeks after treatment.
RESULTS: The improvement of NRS and ODI in the enhanced group was greater than those of the non-enhanced group, at one week and 4 weeks after TFESI (P < 0.05). However there was no significant difference in improvement of NRS and ODI between pre-DRG only enhanced group and pre-DRG and post-DRG enhanced group at one week and 4 weeks after TFESI. LIMITATIONS: Retrospective chart review with a small sample size.
CONCLUSION: The improvement of NRS and ODI in the enhanced group was significantly greater than those of the non-enhanced group after TFESI. Radicular pain and functional impairment in the presence of gadolinium enhancing spinal neural structures and lumbar disc herniation may be more responsive to TFESI than patients without enhancing neural structures.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25794217

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  6 in total

1.  The Successful Treatment of Herniated Lumbar Discs That are Refractory to Repeated Epidural Steroid Injection by Using a Navigable Percutaneous Disc Decompression Device: A Case Series.

Authors:  Min Young Lee; Mathieu Boudier-Revéret; Hee Kyung Cho; Min Cheol Chang
Journal:  J Pain Res       Date:  2020-07-22       Impact factor: 3.133

2.  Spinal nerve signal intensity on Dixon T2-weighted water-only sequence: an important outcome predictor after lumbar transforaminal epidural injection.

Authors:  Yong Hee Kim; Hyo Jin Kim; Jiwoon Seo; Jee Won Chai; Hyun-Gul Song; Yoon-Hee Choi; Dong Hyun Kim
Journal:  Eur Radiol       Date:  2021-06-16       Impact factor: 5.315

3.  Comparative Effectivenesses of Pulsed Radiofrequency and Transforaminal Steroid Injection for Radicular Pain due to Disc Herniation: a Prospective Randomized Trial.

Authors:  Dong Gyu Lee; Sang-Ho Ahn; Jungwon Lee
Journal:  J Korean Med Sci       Date:  2016-06-24       Impact factor: 2.153

4.  Comparison between bipolar pulsed radiofrequency and monopolar pulsed radiofrequency in chronic lumbosacral radicular pain: A randomized controlled trial.

Authors:  Min Cheol Chang; Yun Woo Cho; Sang Ho Ahn
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

5.  The Prognostic Value of Enhanced-MRI and Fluoroscopic Factors for Predicting the Effects of Transforaminal Steroid Injections on Lumbosacral Radiating Pain.

Authors:  Yun Suk Jung; Jee Hyun Suh; Ha Young Kim; Kyunghoon Min; Yoongul Oh; Donghwi Park; Ju Seok Ryu
Journal:  Ann Rehabil Med       Date:  2016-12-30

6.  Transforaminal epidural steroid injection combined with radio frequency for the treatment of lumbar disc herniation: a 2-year follow-up.

Authors:  Wen-Bo Wei; Sha-Jie Dang; Ling Wei; Tian Liu; Jue Wang
Journal:  BMC Musculoskelet Disord       Date:  2021-04-12       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.